As of October 31, 2019, the largest concentration of Candida auris cases — 427 of 911 confirmed cases — is in New York4, according to an article on the Infection Control Today website.
“Approximately 3 years into the New York outbreak, these pan-resistant isolates still appear to be rare, but their emergence is concerning,” investigators have said.
C. auris cases in New York are primarily concentrated among hospital patients and nursing home residents in New York City.
The investigators recommended that patients on antifungal treatment for C. auris should be monitored closely for clinical improvement, and follow-up cultures should be obtained.
5 Reasons Engineering is the Edge in Healthcare Master Planning
Building an AI-Ready Healthcare Facility 
Family Medical Associates of Raleigh Reports April 2026 Data Breach
Every Detail Matters: A Patient's Story of Healing, Hope and Healthcare Facilities
Geisinger Wyoming Valley Medical Center Tops Off New 11-Story Tower